Ningbo Shouzheng Medicinal Research

Ningbo Shouzheng Medicinal Research Co., Ltd. is a Chinese pharmaceutical research and development company founded in 2017 and based in Ningbo, Zhejiang. The company specializes in the development of generic and complex generic drug formulations, with a focus on small molecules and nanoparticle-based drug delivery systems. Its notable pipeline includes Memantine Hydrochloride Tablets for Alzheimer's disease, Pregabalin Capsules for neuropathic pain, and a nanoparticle formulation of Paclitaxel (albumin-bound) for breast cancer. Ningbo Shouzheng operates as a closely affiliated R&D entity to Hainan Shuangcheng Pharmaceutical, frequently transferring its developed drug technologies and ANDA rights to Shuangcheng for commercialization.